The measurement of reverse transcriptase (RT) activity is a common procedure utilized in the field of human retrovirology and has, to date, played a prominent role int he isolation and characterization of human retroviruses. In addition, RT measurements of tissue culture specimens obtained from AIDS patients is an adjunct to various therapeutic regimes used in the treatment of AIDS. The goal of this Phase I study is to develop a rapid and accurate ELISA-based RT assay that would permit such assays to be performed more economically, with no requirement for radioisotopes, and to assist in the continued search for additional human retroviruses. The Phase I goals of this research are to develop an RT assay which would incorporate the performance and quantitation of RT reactions within the wells of 96-well microtiter plates. The synthetic homopolymers (poly[rC].oligo[dT], required as template-primers for the RT reaction, will be immobilized in wells of 96-well microtiter plates used to perform the RT assay. The reaction will be quantitated by the use of rabbit antibodies, conjugated to biotin, developed against synthetic DNA-RNA homopolymers. The immunologic portion of the assay will be completed by standard ELISA technology utilizing streptavidin conjugated to peroxidase. A comparative evaluation of various methodologies to immobilize the synthetic template- primers will be performed along with the optimization of the final RT assay format.

Project Start
1989-09-30
Project End
1990-03-31
Budget Start
1989-09-30
Budget End
1990-03-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Cellular Products, Inc.
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14202